Advertisement
UK markets close in 54 minutes

  • FTSE 100

    8,057.57
    +17.19 (+0.21%)
     

  • FTSE 250

    19,583.63
    -135.74 (-0.69%)
     

  • AIM

    752.75
    -1.94 (-0.26%)
     

  • GBP/EUR

    1.1662
    +0.0017 (+0.15%)
     

  • GBP/USD

    1.2503
    +0.0041 (+0.32%)
     

  • Bitcoin GBP

    50,799.83
    -1,275.45 (-2.45%)
     

  • CMC Crypto 200

    1,379.37
    -3.20 (-0.23%)
     

  • S&P 500

    5,005.39
    -66.24 (-1.31%)
     

  • DOW

    37,822.48
    -638.44 (-1.66%)
     

  • CRUDE OIL

    82.23
    -0.58 (-0.70%)
     

  • GOLD FUTURES

    2,337.50
    -0.90 (-0.04%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,869.11
    -219.59 (-1.21%)
     

  • CAC 40

    7,990.85
    -101.01 (-1.25%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Hyaluronic Acid Global Market Outlook: A USD 14.4 Billion Market by 2028

Research and Markets
·5-min read

Dublin, Jan. 13, 2022 (GLOBE NEWSWIRE) -- The "Global Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), Region (North America, APAC), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global hyaluronic acid market size is expected to reach USD 14.4 billion by 2028, expanding at a CAGR of 7.19%.

Factors such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time, are high impact rendering drivers for this market. The market is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is fueling the growth. The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting consumers.

Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in the inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious about their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed as the "Zoom Boom" or the "Zoom effect." Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan.

The market in Asia Pacific is anticipated to register the fastest CAGR during the forecast period due to the rising geriatric population in China and Japan, which drives demand for anti-aging products and services. Increasing awareness about the applications of hyaluronan and its efficacy also fuels the demand. In addition, stabilizing economies leave the middle-class population with surplus money to spend on these procedures. The European market for orthopedic biomaterials has undergone impressive changes over the last 2 years. The high demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the market in Europe.

Report Highlights

  • The osteoarthritis segment held the largest share in 2020 due to increased cases of obesity resulting in osteoarthritis & joint pain, which have boosted the product demand as a treatment

  • Hyaluronic acid acts as a shock absorber or a cushion and lubricates the joints, thus helping in the proper functioning

  • There are a number of ophthalmic surgical products that use hyaluronan/hyaluronic acid as an active ingredient. These include Vitrax, Healon, Amivisc Plus, Amvisc, Hylan G-F20, and Opegan

  • The increasing prevalence of age-related eye diseases, dry eye syndrome, adult-vision impairments, and chronic diseases, such as diabetes, are major factors leading to market growth for the ophthalmic application segment

  • Growing preference for short-treatment regimens, even though high priced, and high prevalence of target diseases are the key factors driving the market in North America

ADVERTISEMENT


Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.1.2.1 Facial Injectable market
3.1.2.2 Knee replacement/implants market
3.2 User Perspective Analysis
3.2.1 Consumer Behavior Analysis
3.2.2 Market Influencer Analysis
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing geriatric population
3.3.1.2 Growing awareness for antiaging products
3.3.1.3 High prevalence of target diseases
3.3.2 Market Restraint Analysis
3.3.2.1 Associated adverse effects of hyaluronic acid
3.3.2.2 High cost of products and related services
3.4 Business Environment Analysis Tools
3.5 Penetration & Growth Prospect Mapping
3.6 Major Deals & Strategic Alliances Analysis
3.7 Impact of COVID-19: Qualitative Analysis

Chapter 4 Hyaluronic Acid Market: Application Analysis
4.1 Hyaluronic Acid Market Share analysis, 2020 & 2028
4.2 Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the Application
4.3.1 Osteoarthritis
4.3.2 Dermal Fillers
4.3.3 Ophthalmic
4.3.4 Vesicoureteral Reflux

Chapter 5 Hyaluronic Acid Market: Regional Analysis
5.1 Regional Market Share Analysis, 2020 & 2028
5.2 Regional Market Snapshot
5.3 Market Size & Forecasts and Trend Analysis, 2020 to 2028

Chapter 6 Reimbursement Outlook
6.1 Reimbursement by Product
6.2 Reimbursement by Region

Chapter 7 Competitive Analysis

  • Allergan

  • Sanofi

  • Genzyme Corporation

  • Anika Therapeutics Inc.

  • Salix Pharmaceuticals

  • Seikagaku Corporation

  • F. Hoffman-La Roche AG

  • Galderma Laboratories L.P.

  • Zimmer Biomet

  • Smith & Nephew PLC

  • Ferring B.V

  • Lifecore Biomedical, LLC

  • HTL Biotechnology

  • Shiseido Company Ltd

  • Bloomage Biotechnology Corporation Ltd

  • LG Life Sciences Ltd (LG CHEM.)

  • Maruha Nichiro Inc.

For more information about this report visit https://www.researchandmarkets.com/r/cdot85

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900